84 related articles for article (PubMed ID: 14975520)
21. Successful liver retransplantation for recurrent hepatopulmonary syndrome.
Rajwal SR; Davison SM; Prasad R; Brownlee K; McClean P
Pediatr Transplant; 2007 Dec; 11(8):927-30. PubMed ID: 17976130
[TBL] [Abstract][Full Text] [Related]
22. Norfloxacin therapy for hepatopulmonary syndrome: a pilot randomized controlled trial.
Gupta S; Faughnan ME; Lilly L; Hutchison S; Fowler R; Bayoumi AM
Clin Gastroenterol Hepatol; 2010 Dec; 8(12):1095-8. PubMed ID: 20816858
[TBL] [Abstract][Full Text] [Related]
23. Diammonium glycyrrhizinate alleviates hepatopulmonary syndrome via restoring superoxide dismutase 3 activity in rats.
Zhao X; Liu J; Yang S; Chen C; Yin H; Li T; Wang Q; Li X; Lin Y; Cai D
Eur J Pharmacol; 2017 Jul; 807():144-150. PubMed ID: 28435094
[TBL] [Abstract][Full Text] [Related]
24. Hepatopulmonary syndrome: role of nitric oxide and clinical aspects.
Rolla G
Dig Liver Dis; 2004 May; 36(5):303-8. PubMed ID: 15191196
[TBL] [Abstract][Full Text] [Related]
25. Pediatric hepatopulmonary syndrome is seen with polysplenia/interrupted inferior vena cava and without cirrhosis.
Gupta NA; Abramowsky C; Pillen T; Redd D; Fasola C; Heffron T; Romero R
Liver Transpl; 2007 May; 13(5):680-6. PubMed ID: 17457897
[TBL] [Abstract][Full Text] [Related]
26. Utility of pulse oximetry screening for hepatopulmonary syndrome.
Arguedas MR; Singh H; Faulk DK; Fallon MB
Clin Gastroenterol Hepatol; 2007 Jun; 5(6):749-54. PubMed ID: 17392034
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary arterial coil embolization for the management of persistent type I hepatopulmonary syndrome after liver transplantation.
Saad NE; Lee DE; Waldman DL; Saad WE
J Vasc Interv Radiol; 2007 Dec; 18(12):1576-80. PubMed ID: 18057294
[TBL] [Abstract][Full Text] [Related]
28. Development of hepatopulmonary syndrome and portopulmonary hypertension in a paediatric liver transplant patient.
Shah T; Isaac J; Adams D; Kelly D;
Pediatr Transplant; 2005 Feb; 9(1):127-31. PubMed ID: 15667626
[TBL] [Abstract][Full Text] [Related]
29. The importance of predicting the prognosis in patients with hepatopulmonary syndrome: a simple scoring system.
Bottari G; Mazzeo AT; Santamaria LB
Transplant Proc; 2006 Apr; 38(3):795-7. PubMed ID: 16647473
[TBL] [Abstract][Full Text] [Related]
30. Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis.
Biecker E; Neef M; Sägesser H; Shaw S; Koshy A; Reichen J
Liver Int; 2004 Aug; 24(4):345-53. PubMed ID: 15287858
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary vascular abnormalities in cirrhosis.
Herve P; Le Pavec J; Sztrymf B; Decante B; Savale L; Sitbon O
Best Pract Res Clin Gastroenterol; 2007; 21(1):141-59. PubMed ID: 17223502
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of screening for hepatopulmonary syndrome in liver transplant candidates.
Roberts DN; Arguedas MR; Fallon MB
Liver Transpl; 2007 Feb; 13(2):206-14. PubMed ID: 17205561
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of a myeloperoxidase gene polymorphism and inducible nitric oxide synthase expression in cirrhotic patients with hepatopulmonary syndrome.
Wang Y; Wang W; Zhang Y; Zhao X; Yang D
J Huazhong Univ Sci Technolog Med Sci; 2010 Aug; 30(4):437-42. PubMed ID: 20714866
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the protective effects of quercetin in the hepatopulmonary syndrome.
Tieppo J; Vercelino R; Dias AS; Silva Vaz MF; Silveira TR; Marroni CA; Marroni NP; Henriques JA; Picada JN
Food Chem Toxicol; 2007 Jul; 45(7):1140-6. PubMed ID: 17306429
[TBL] [Abstract][Full Text] [Related]
35. Resolution of hepatopulmonary syndrome after auxiliary partial orthotopic liver transplantation in Abernethy malformation. A case report.
Emre S; Arnon R; Cohen E; Morotti RA; Vaysman D; Shneider BL
Liver Transpl; 2007 Dec; 13(12):1662-8. PubMed ID: 18044784
[TBL] [Abstract][Full Text] [Related]
36. [Hepatopulmonary syndrome characteristics in hepatic cirrhosis associated with COPD].
Nevzorova VA; Pestrikova TL; Kochetkova EA; Osvald M; Doutreleau S; Massard G
Ter Arkh; 2009; 81(3):15-9. PubMed ID: 19459415
[TBL] [Abstract][Full Text] [Related]
37. Hepatopulmonary syndrome.
Agrawal G; Kumar N; Rosha D
J Assoc Physicians India; 2008 Apr; 56():265-7. PubMed ID: 18702392
[TBL] [Abstract][Full Text] [Related]
38. Cirrhotic rats with bacterial translocation have higher incidence and severity of hepatopulmonary syndrome.
Sztrymf B; Libert JM; Mougeot C; Lebrec D; Mazmanian M; Humbert M; Herve P
J Gastroenterol Hepatol; 2005 Oct; 20(10):1538-44. PubMed ID: 16174071
[TBL] [Abstract][Full Text] [Related]
39. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats.
Wei CL; Hon WM; Lee KH; Khoo HE
Liver Int; 2005 Jun; 25(3):647-56. PubMed ID: 15910502
[TBL] [Abstract][Full Text] [Related]
40. Resolving impaired response to exercise in hepatopulmonary syndrome after liver transplantation.
Nusair S; Eid A; Bardach E; Berkman N
Int J Cardiol; 2005 Jul; 102(3):533-5. PubMed ID: 16004905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
